Effect of glucose and pyruvate in acidic and non-acidic peritoneal dialysis fluids on leukocytes cell functions. A new peritoneal dialysate containing pyruvate anions has been tested for its effects on cell functions and compared with conventional lactate and bicarbonate based solutions. The dialysate has a final pH of 5.4 to 5.6 and is composed of 1.36 to 3.86% glucose-monohydrate, 132 mmol/liter sodium, 1.75 mmol/liter calcium, 0.75 mmollliter magnesium, 102 mmol/liter chloride and 35 mmol/liter pyruvate. For cytotoxicity testing peritoneal macrophages and peripheral blood mononuclear cells (PBMC) were exposed to conventional lactate dialysate, pyruvate dialysate, bicarbonate dialysate and a control medium RPMI 1640 (Biochrom KG, Berlin, Germany), followed by activation with different bacterial stimuli. In addition, the study further investigated the effect of varying glucose concentration in the different dialysates ranging from 0 to 3.86% and pH changes between 5.2 and 7.4 on the cytotoxicity effect on the selected cells. Mononuclear cells exposed to pyruvate-based dialysate before stimulation with endotoxin exhibited a tumor necrosis factor (TNF)-mRNA signal comparable to those of cells exposed to RPMI. In contrast, exposure to lactate-based dialysate completely inhibited TNF-mRNA synthesis. In addition, cytokine synthesis in macrophages and PBMCs after exposure to pyruvate was less inhibited when compared to the corresponding levels measured after exposure to lactate. The chemotactic response of polymorphonuclear cells and °2 generation in all tested cell types after exposure to pyruvate was found not to be inhibited, whereas a complete inhibition was observed after exposure to lactate. The results demonstrate that cytotoxicity effects of peritoneal dialysate on cell lines can be minimized by using a new dialysate formulation containing pyruvate anions instead of lactate. 13]. Other dialysate components which may separately or synergistically act with glucose to induce cytotoxicity are the low pH [14] and the presence of lactate anions (35 mmol!liter) in racenlic mixtures containing both the D-and L-forms [14] .
containing pyruvate anions has been tested for its effects on cell functions and compared with conventional lactate and bicarbonate based solutions. The dialysate has a final pH of 5.4 to 5.6 and is composed of 1.36 to 3.86% glucose-monohydrate, 132 mmol/liter sodium, 1.75 mmol/liter calcium, 0.75 mmollliter magnesium, 102 mmol/liter chloride and 35 mmol/liter pyruvate. For cytotoxicity testing peritoneal macrophages and peripheral blood mononuclear cells (PBMC) were exposed to conventional lactate dialysate, pyruvate dialysate, bicarbonate dialysate and a control medium RPMI 1640 (Biochrom KG, Berlin, Germany), followed by activation with different bacterial stimuli. In addition, the study further investigated the effect of varying glucose concentration in the different dialysates ranging from 0 to 3.86% and pH changes between 5.2 and 7.4 on the cytotoxicity effect on the selected cells. Mononuclear cells exposed to pyruvate-based dialysate before stimulation with endotoxin exhibited a tumor necrosis factor (TNF)-mRNA signal comparable to those of cells exposed to RPMI . In contrast, exposure to lactate-based dialysate completely inhibited TNF-mRNA synthesis. In addition, cytokine synthesis in macrophages and PBMCs after exposure to pyruvate was less inhibited when compared to the corresponding levels measured after exposure to lactate. The chemotactic response of polymorphonuclear cells and °2 generation in all tested cell types after exposure to pyruvate was found not to be inhibited, whereas a complete inhibition was observed after exposure to lactate. The results demonstrate that cytotoxicity effects of peritoneal dialysate on cell lines can be minimized by using a new dialysate formulation containing pyruvate anions instead of lactate. 13] . Other dialysate components which may separately or synergistically act with glucose to induce cytotoxicity are the low pH [14] and the presence of lactate anions (35 mmol!liter) in racenlic mixtures containing both the D-and L-forms [14] .
To avoid these toxic effects of dialysate chemicals, newly formulated dialysis solutions containing peptides [15, 16] , glycerol [17] , or glucose polymers as osmotic agents [18, 19] , or bicarbonate instead of lactate, have been proposed [20] . Recently, we demonstrated that peritoneal dialysis solution buffered with pyruvate had less negative effects on the peritoneal cell function than lactate based dialysates [21, 22] . This study further analyzed the effects of pyruvate on the cell functions by varying the pH, the glucose concentration, and finally by combining pyruvate and bicarbonate. To test whether the mixture of pyruvate with varying levels of glucose at different pHs or in the combination with bicarbonate interferes with the leukocyte response to bacterial pathogens, we challenged dialysate exposed cells with different bacterial agents. Human peripheral blood mononuclear cells and human peritoneal macrophages were tested for chemotactic response, metabolic activity and cytokine release after exposition to conventional lactate dialysate, and the new pyruvate dialysate.
Methods Preparations of test solutions
Lactate-based peritoneal dialysate solutions have acute deleterious effects on peritoneal macrophages and granulocytes possibly leading to impaired host defense and increased incidence of peritonitis [1, 2] . In this respect, it has been demonstrated that commercially available glucose and lactate based peritoneal dialysates reduce the capacity of leukocytes for chemotaxis, bacterial killing [3] [4] [5] [6] , and production of monokines [7, 8] . In addition, utilization of these standard dialysate solutions has been shown to cause an inhibition of mesothelial cell proliferation [9, 10] resulting in peritoneal membrane damage in the chronic situation.
Toxic properties of CAPD solutions appear to be related to high glucose concentrations (1.36 to 3.86%), as demonstrated in previous studies that glucose inhibits cell proliferation and RNA mmol/liter, and lactate 35 mmol/liter. The pH of the lactate dialysate was adjusted to between 5.4 and 5.8 using acetic acid. The solutions without pyruvate or lactate were also prepared as described above, with an inclusion of 35 mmol bicarbonate instead. For testing in acidic conditions, the pH of these solutions were adjusted from 5.4 to 5.8 with acetic acid. The osmolality of all glucose containing solutions was approximately 340 mOsmfkg (1.36% glucose) and 480 mOsm/kg (3.86% glucose), respectively.
Cell isolation and preparations
Polymorphonuclear cells (PMN) from peripheral blood of healthy donors were isolated from 20 ml blood by dextran sedimentation (6% dextran, molecular wt 70,000) followed by Ficoll (Pharmacia, Upsala, Sweden) density gradient centrifugation (160 g for 35 mm at 4°C). The PMN were counted in a Neubauer chamber and resuspended in Hank's balanced salt solution, HBSS (Biochrom, Berlin, Germany) at 5 X 106 cells/ml.
Preparations contained > 95% PMN as determined by light microscopy. The PMN cell viability was determined by Trypan blue exclusion test and always exceeded 95%.
Peripheral blood mononuclear cells from healthy donors (PBMC) were separated from heparinized blood samples (10 lU/mI) by density gradient centrifugation over Ficoll-Hypaque (Pharmacia). The phase containing PBMC was collected and washed with saline (3 times), counted, resuspended in RPMI (Biochrom, Berlin, Germany; RPMI is the medium formulation from the "Roosevelt Park Memorial Institute") containing 1% pyrogen-free bovine serum albumin (BSA), and prepared immediately for cytokine tests. The pyrogen tests were assayed by use of LAL Mallinckrodt (Limulus Amebocyte Lysate test) from Sangtec Diagnostica (Germany). The test sensitivity was 6 pg/mI LPS (lipopolysaccharide) as determined from standard LPS included in the kit (FDA-Reference-Endotoxin from E. coli-055:B5 from Sigma, Deisenhofen, Germany).
Macrophages (PM) were separated from peritoneal effluent stored on ice during collection and after a four hour dwell of a 2 liter infusion of 0.9% saline in seven CAPD patients without peritonitis for a duration not less than six months. The entire saline drainage volume ranging from I to 2 liters was centrifuged at 300 X g for 30 minutes. The total drainage volume yielded 5 X io to 6 X 106 cells. The average cell composition was 80% macrophages, 14% lymphocytes, 4% neutrophils, and 2% eosinophils. The macrophages were not pooled for the various studies. Macrophages isolated from each individual patient's peritoneal effluent, were used separately for the complete test including the control and the formulated solutions.
Preparation of the bacterial toxins
Lipopolysaccharide (LPS) from E. coli (055 B5) and staphylococcal enterotoxin (SEB) were purchased from Sigma. Exotoxin A was purified from Pseudomonas aeruginosa strain PA 103 according to Liu [23] . The purification of exotoxin was performed by three chromatographic steps according to the method described by Leppla [241. After the three chromatographic steps on batch DEAE-Sepharose (Pharmacia-LKB), DEAE-Sepharose and hydroxyapatite (Bio-Rad Laboratories GmbH, MUnchen, Germany), the final preparation was concentrated by precipitation with ammonium sulfate and dialyzed against a buffer [0.01 mol/liter Tris(hydroxymethyl)aminomethane (Tris)-hydrochloride, pH 8.11. The purity of exotoxin A was assessed with SDS-PAGE clectrophoresis and Western blotting using a commercially available polyclonal goat anti-exotoxin A (List Biological Lab, Inc., Campbell, CA, USA).
Chemotaxis measurement
Chemotaxis of peripheral neutrophils (PMN) was performed after a five minute exposure with different solutions. For evaluation of the chemotactic response, the migration distance of cells under agarose in tissue culture dishes was measured as described by Nelson and Herron [251. Separated neutrophils were resuspended in Hanks' balanced salt solution (HBSS) and centrifuged at 500 X g for eight minutes. The cell pellet was resuspended in HBSS, evaluated for cell number and cell viability and diluted to 3 x iO neutrophils per ml. The center well of each dish was filled with 10 jxl of the chemotactic fMLP (N-formyl-Met-Leu-Phe) sample (10 mol). Samples of 10 jid containing 3 x i0 neutrophils were filled in the outer wells. Agarose plates were incubated for two hours at 37°C in a humidified CO2 (5%) incubator to allow cells to migrate. The cells were fixed with formaldehyde (37%) for 30 minutes and decanted, the agarose was removed from the culture, and the cells were then stained with May-Grunwald's solution. The potency of the chemotaxis was scored by the measurement of the effective migration distance: cells migrate towards the chemotactic gradient of the fMLP sample (distance X) and the control medium random migration distance (Y), X-Y represented the effective migration towards the chemotactic samplc.
Superoxide anion (02-) determination Peripheral blood mononuclear cells (PBMC), peritoneal macrophages or peripheral neutrophils (PMN) were incubated for five minutes exposure with different test solutions (RPMI solution, pyruvate dialysate, and lactate dialysate). After the initial incubation with the different test solutions the cells were washed twice with phosphate buffer (PBS) containing 10 jig/mI glucose, and the cell suspensions were further incubated at 37°C for 15 minutes in PBS buffer containing opsonized zymosan (5 x 106 PMN; 0.5 ml PBS; 0.5 ml opsonized zymosan, in 0.25 ml cytochrome C solution; 0.1 ml pooled human serum) as the stimulant. Superoxide dismutase inhibitable 02 radical formation was determined by the reduction of cytochrome C at 546 nm in a Beckman spectral photometer. The sensitivity of the system was drawn to -0.O5 nmol/liter 02.
Cytokine measurements
Before stimulation, cells were exposed to test solutions for a period of 5, 15 and 30 minutes. PBMC and PMN were resuspended in sterile RPMI (Biochrom, Berlin; Germany) buffered with 20 mrvi HEPES (Gibco-BRL, Eggenstein, Germany) to pH 7.4, and supplemented with 1% bovine serum albumin (BSA), 100 U/mI penicillin, 100 j.tg/ml streptomycin, and 2 m of t-glutamine. Cell suspensions were adjusted to 2.5 x 106/ml (PBMC) and 0.5 x 106/ml (PMN). The total volume of each well was adjusted to 1 ml with RPM! and different stimuli were used in the following concentrations: I ng/ml concentration LPS (E. coli 055; B5; Sigma Chemical Co.), exotoxin A (5 ng/ml), and enterotoxin B (5 ng/ml).
The cells were incubated in 24-well culture plates (Nunc, Roskilde, Denmark) in a 5% CO, atmosphere at 37°C for 24 hours. For the ELISA measurements (Biermann, Bad Nauheim, Germany;), cells were then lysed by repeated freezing and the supernatants were stored frozen at -70°C until assayed for interleukin ibeta (IL-lp), tumor necrosis factor alpha (TNF-a) and interleukin 6 (lL-6). The results of the assays should distinguish between cell associated and extraccllular cytokine content.
The extraction of the messenger RNA was performed by the RNAzo1 method [25] using 0.5 ml RNAzol (Peasel and Lorei, Germany) for 2.5 X 106. RNA was reverse transcribed into eDNA with M-MLV (Moloney murine leukemia virus) reverse transcriptase (Gibco-BRL Life Technologies Ltd.), using the random hcxamers method as previously described [25] . The reaction Ltd., London, UK). PCR was performed from 24 cycles to 32 cycles in four steps consisting of two cycles each. PCR was performed for cs-actin (control) and for TNF-cs. One-tenth of the PCR reaction products were separated by electrophoresis (BioRad Laboratories GmbH, Krefeld, Germany) on 1.5% agarose gels (Flowgen Instruments Ltd, Sittinghourne, UK) and stained with ethidium bromide (Sigma Chemicals). As a control, equal amounts of RNA were used for the amplification and expression of the a-actin mRNA. The gels were then photographed by UV light.
Effects of high glucose concentrations on cell cytotoxicity of dialysate solutions The effects of high glucose concentrations in mixtures containing pyruvate-based dialysate solutions or in combinations involving bicarbonate and pyruvate were later investigated in an effort to establish a possible improvement over the conventional peritoneal dialysates. The experiments were designed to compare the effects of different dialysis formulations on selected aspects of cell functions. The formulations tested were as follows: (1) of granulocytes and 02 production in peritoneal macrophages, peripheral blood mononuclear cells, and peripheral granulocytes were investigated. As shown in Figure 1 , the levels of 02 generation in granulocytes, peripheral mononuclear cells, and peritoneal macrophages after five minutes exposure to pyruvate dialysate were in the same range as those observed in cells exposed to RPMJ, whereas a complete inhibition was found in cells exposed to the conventional lactate dialysate (P < 0.01; lactate vs. RPM!). Pyruvate dialysate and lactate dialysate were compared by measuring 02 release. Granulocytes released approximately 40 times (P < 0.001; pyruvate vs. lactate), activated peritoneal macrophages nearly 20 times (P < 0.01; pyruvate vs. lactate), and activated peripheral blood monocytes six times (P < 0.001; pyruvate vs. lactate) more 02 when exposed to pyruvate as opposed to lactate dialysate.
The chemotactic migration of peripheral granulocytes exposed to pyruvate dialysate was 10.7 0.27 mm (mean SD), approximately in the same range as that of peripheral granulocytes after exposure to RPMI (12.5 0.55 mm). In contrast, chemotaxis of peripheral granulocytes exposed to lactate dialysate was not detectable in all experiments.
Cytokine reactions
As shown in Figure 2 , the incubation of peripheral blood mononuclear cells with lactate dialysate totally blocked the spontaneous transcription of TNF-a mRNA. The cells exposed to pyruvate dialysate, however, showed a TNF-a mRNA signal similar to that observed after exposure to RPMI control medium. After one hour stimulation with LPS, there was a marked increase in TNF-a mRNA of cells exposed to the pyruvate dialysate and RPMI whereas the lactate exposed cells still did not produce the TNF-a transcript.
In the investigations of cytokine synthesis at the intracellular and extracellular levels by peripheral mononuclear cells initiated by stimulation with different bacterial toxins (Fig. 3) , measurements of IL-I, TNF-, and IL-6 synthesis in the cell supernatant confirmed the PCR results and demonstrated that pyruvate dialysate has limited inhibitory effects at the level of cytokine synthesis. After exposure of peripheral blood mononuclear cells to pyruvate-hased solutions, all tested bacterial stimuli induced a generation of TNF-a, IL-1f3 and IL-6, but at an average level of 30% less than the RPM! exposed cells. The cytokine synthesis in Before bacterial toxin stimulation the monocytes were exposed for 15 minutes to different solutions (AT = 9; mean SD): (E) RPM!, () pyruvate and (iii) lactate-based dialysates. The glucose concentration in both pyruvate and lactate dialysates was 1.36% and the pH was between 5.4 and 5.6. The negative control (U) was a 24-hour cell culture with neither stimulation or exposition of the cells to the test solutions. The results indicated a moderate reduction in the endotoxin and enterotoxininduced cytokine synthesis when RPM! medium was compared with pyruvate. !n contrast, a markedly significant reduction was observed (P < 0.01) for lactate-based dialysate.
pyruvate exposed cells was reduced by 4.6 to 19% when stimulated with staphylococcal cnterotoxin, 23.1% to 29% when stimulated with pseudomonas exotoxin, and 22% to 65% when stimulated with LPS as compared to cells exposed to RPM!. However, after Experimental conditions for the negative control (u), glucose concentrations and the pH of the pyruvate and lactate dialysates were as described in Figure 3 . Pyruvate-based dialysate exposed macrophages generated significantly greater levels of cytokines (P < 0.01) as compared to those exposed to lactate-based dialysate. However, pyruvate-based dialysate exposed peritoneal macrophages showed significantly less (P < 0.01) cytokine synthesis as compared to the control RPMI medium.
exposure to lactate dialysate there was a much stronger reduction of the cytokine synthesis of up to 80% when compared to RPM! exposed cells independent of the bacterial stimulant used. Further investigation into cytokine synthesis in peritoneal macrophages stimulated with LPS as shown in Figure 4 , indicated that pyruvate-based dialysate-exposed macrophages generated significantly greater levels of cytokines (P < 0.01; pyruvate vs. lactate) than those exposed to lactate dialysate. Pyruvate exposed peritoneal macrophages showed 42% (for TNF), and 29.5% (for IL-1/3) less cytokine synthesis than the cells exposed to the control medium (P < 0.01, pyruvate vs. control medium). In contrast, lactate dialysate exposed macrophages showed a much more pronounced inhibition by about 86% (for TNF), and 79% (for IL-1/3), when compared to the cells exposed to the control medium (P < 0.001; lactate vs. control medium).
As shown in the Figures 3 to 5, pyruvate dialysate had by far less inhibitory effects on cytokine production than lactate, it was therefore concluded that pyruvate maintains cell functions even at low p1-I or in the presence of high glucose concentration. To establish further the effect of pyruvate in relation to glucose or the pH, a series of eight experiments were performed in the presence and absence of pyruvate and variables of these experiments were pyruvate (0 or 35 mmol/liter), glucose (0 or 2.5%) and pH (5.4 or 7.4). As shown in Figure 5 , activated monocytes exposed to the medium containing pyruvate at low pH and without glucose synthesized cytokines at the same level as those cells exposed to the medium without glucose or pyruvate. In the medium containing glucose without pyruvate at low pH, the cytokine production was significantly reduced (P < 0.01) to about 45% of the magnitude found in cells exposed to the corresponding medium lacking pyruvate, 35 mmollliter bicarbonate was present. The glucose based solutions contained 2.5% (wt/vol). In the absence of pyruvate in the test dialysate solutions containing glucose and at low pH there was a significant reduction in peripheral blood mononuclear cell cytokine synthesis (P < 0.01) as compared to the corresponding compositions containing pyruvate. In an acidic medium containing no added glucose or pyruvate, cytokine generation was significantly greater (P < 0.001) than solutions containing glucose at low pH.
containing pyruvate. The observed cytokine generation after cell exposure to a pyruvate-free or glucose-free acidic medium was approximately 62% higher than results obtained after cell exposure to the pyruvate-free but glucose-containing acidic medium. Finally, the medium containing pyruvate and glucose at pH 7.4 produced results similar to those observed after cell exposure to the same medium at low pH. This therefore indicates that in the solutions containing glucose but in the absence of pyruvate, cytokine production was significantly reduced (P < 0.01) to approximately 39% in activated peripheral blood mononuclear cells.
To compare the effects of pyruvate and lactate as a function of the glucose concentration on the peripheral monocyte IL-113 synthesis, the glucose concentration was varied in the medium with or without pyruvate or lactate respectively. As shown in Figure 6 , in the absence of pyruvate or lactate, the increase of the glucose concentration (0.5%, 1.5%, 2.5%, and 4%) successively reduced the IL-ip synthesis. In the presence of lactate and the absence of pyruvate, IL-1 synthesis was subsequently reduced to 20% at 0.5 glucose concentration, and totally inhibited at glucose concentrations greater than 1.5% (P < 0.0001). In contrast, the variation of glucose concentration in the presence of pyruvate or lactate appeared to have no effect (at a glucose concentration range of 0.5 to 1.5%) or had only a limited effect (at glucose concentration range 2.5 to 4%; P < 0.01) on the monocyte function.
To determine the variability in the cell response parameters as shown in Table 1 , at low pH and high glucose concentration, the pyruvate solution indicated significantly less toxic effects on all tested cells than the bicarbonate solution at pH 7.4 (P < 0.01). In addition, at physiological pH the combination of bicarbonate and pyruvate (30 mmol/liter to 10 mmol/liter, respectively) significantly reduced (P < 0.01) cell cytotoxicity as compared to the combination of bicarbonate with lactate.
Discussion
It has been demonstrated in previous studies that lactate-based CAPD solutions reduce the viability, proliferation and immunological function of polymorphonuclear cells, peritoneal macrophages, and mesothelial cells [2- 91. This study focused on the effect of the substitution of sodium lactate with sodium pyruvate in a new type of CAPD dialysate on the viability, proliferation and immunological functions of leukocytes. The findings indicate that pyruvate based dialysate minimizes the cytotoxic effects of pentoncal (macrophages) and peripheral blood leukocytes (granulocytes and monocytes) after exposure to conventional racemic lactate dialysate, pyruvate dialysate, and RPM! as the control neutral solution. The parameters investigated were 02 production, chemotactic response, cytokine-mRNA detection, and cytokine synthesis after stimulation. We have found that cells preincubated with pyruvate dialysate and RPMI exhibited the same cytokine-mRNA signals after one to two hours stimulation with endotoxin. Accordingly cytokine generation after 24 hours stimulation was not suppressed in the pyruvate dialysate-exposed cells.
In contrast, conventional lactate dialysate totally inhibited the cytokine signal and protein synthesis. Furthermore, the chemotaxis of granulocytes and the °2 generation in macrophages and granulocytes after exposure to pyruvate dialysate was comparable to that observed after RPMI exposure, whereas a complete inhibition of these parameters was found after exposure to lactate dialysate. To substantiate the role of pyruvate in maintaining leukocyte cell functions, the following aspects were demonstrated: (1) glucose has toxic effects on leukocytes independent of pH and lactate, (2) lactate enhances the glucose cytotoxicity, which is neutralized by pyruvate.
According to the metabolism and transport of dialysate chemicals in the peritoneum, the half life of lactate anions in the peritoneum does not exceed 30 minutes. The time relating the dialysate-peritoneum exposure was considered an important aspect of the test procedures used to determine the immunosuppression of the tested cells. Consequently, in the design of our experiments the exposure to lactate or pyruvate was short (5 and 15 mm, respectively) and was performed before stimulation of the tested cells. During stimulation, RPM! was used as the neutral medium to avoid further exposure of cells to high glucose and lactate concentrations. The cytotoxicity of glucose and lactate and the beneficial effects of pyruvate on cell function was maintained during stimulation of up to 24 hours. The cytotoxic properties of lactate-based CAPD solutions have been attributed to: (1) high glucose concentrations [10] ; (2) to the acidity of the dialysate [3] ; (3) to the lactate anions being in racemic mixtures of both D-and L-forms of lactate [29, 30] .
High glucose concentration has been shown to induce cellrespiratory inhibition in tumour cells [31, 32] and in guinea pig spermatozoa [33] . A long time of exposure (5 days) with a glucose concentration of 30 mmol/liter has been shown in the past to inhibit endothelial cell proliferation and DNA synthesis [11, 12] . Sehagiri and Bavister [34] demonstrated an inhibition of hamster blastocyte transformation in culture media containing 5 mmol/ liter glucose. With respect to peritoneal dialysate toxicity, Breborowitz, Rodela and Oreopoulos [101 observed a reduced mesothelial cell proliferation at a glucose concentration of 60 to 90 mmol/liter. The findings in this study have indicated that the media with high glucose content elicits greater inhibition of leukocyte functions compared to the media with lower glucose concentration (Fig. 5) . It is possible that the biochemical mechanisms of glucose toxicity in CAPD may be related to the Crabtree effect. The Crabtree effect has been proposed to be a manifestation of respiratory inhibition in the presence of high glucose concentration or other hexose [32] . This effect includes the contraction of mitochondnia and a decrease in the rate of glucose utilization occurring at the time of respiratory inhibition. According to Koobs [32] , this effect does not inhibit glycolysis, but it may cause inadequate energy generation presumably by decreasing the availability of nicotinamide adenine dinucleotide and/or oxidative potential, which may subsequently depress lactate oxidation to pyruvate. In this context, previous studies have found that the glycolytic pathway provides less ATP in hamster embryos exposed to glucose-rich media [33] . So far, the Crabtree effect has been described only in transformed cells [32, 33] , guinea pig spermatozoa [35] and in hamster blastocytes [34] . This study has demonstrated that the Crabtree effect may also be involved in glucose toxicity on leukocytes.
The use of racemic mixture of lactate anions in conventional CAPD dialysate has been adapted from the parenteral fluid composition known as lactated Ringer's solution developed in the Peritoneal leukocytes utilize lactate as energy substrate during the ingestion of invading microorganisms and senescent host cells [38] , and take up L-lactate preferentially in an acidic environment via a monocarboxylate transporter [39] . It might be speculated that lactate toxicity in CAPD is linked to the same mechanism as glucose toxicity, since pyruvate eliminates both glucose and lactate cytotoxicity. On the other hand, it is possible that lactate oxidation may have been blocked, leading to an insufficient energy production via glycolytic metabolic pathway as a result of the Crabtree effect initiated by the high glucose concentrations in the dialysate. Pyruvate seems to be effective as an alternative energy substrate necessary for leukocyte activation. In this context Seshagiri and Bavister [34] demonstrated previously that only the addition of pyruvate to glucose-containing medium increased blastocyte development, while lactate did not. Pyruvate alone supported development of hamster eight-cell embryos, whether or not the media contained lactate [34j. It has been demonstrated in this study that in the presence of glucose, leukocyte activation increases when pyruvate is present in the dialysate, but not in the presence of lactate. The new pyruvate-containing dialysate might maintain leukocyte functions by providing the cells with an energy source not influenced by the Crabtree effect. We speculate that when pyruvate is used in the dialysate, the glucose-induced respiratory inhibition is reduced, while the oxidation of pyruvate is not diminished as compared to lactatc by glycolysis, and because pyruvate dehydrogenase activity is enhanced rather than depressed by phosphate ions (Pi) deficiency or reduced ATP/ADP. Such observations relating the interaction between the Crabtree effect and pyruvate were made by Linn and Reed in 1969 by using mitochondria from normal tissues. The role of the Crabtree effect in CAPD dialysate toxicity needs to be verified in leukocytes and peritoneal cells by measurements of respiration and the analysis of certain key metabolites.
The clinical applicability of a peritoneal dialysate depends on its capacity to correct metabolic acidosis in uremic patients. In conventional dialysate this is achieved by the 35 mmol/liter sodium lactate which is metabolized to bicarbonate in the liver. Sodium pyruvate (35 mmollliter) should efficiently correct metabolic acidosis since the half-life of pyruvate in vivo is not longer than 5 to 15 minutes because of its rapid hepatic conversion to lactate. In an intravenous pyruvate loading test applied in healthy subjects by van Erven et al [40] , it was demonstrated that 500 mg/kg body wt of sodium pyruvate administered in a period of 10 minutes was completely metabolized in 60 minutes. The in vitro study, therefore, has provided further information that supports the view that sodium pyruvate-based peritoneal dialysis could be clinically applicable. Sodium pyruvate in aqueous solutions is stable, easily sterilizable, and can be prepared during the clinical utilization without difficulties. In severe hepatic disfunction, however, it is important that pyruvate or lactate based dialysis are best be avoided in view of the depressed hepatic metabolism.
